what drugs are glp 1 agonists GLP-1 Agonists: A Comprehensive Overview GLP-1 Receptor Agonists and Research

Human pharmacokinetic values for semaglutide and tirzepatide included for mechanistic reference only

GLP-1R agonism also promotes -cell growth and survival by stimulating the expression of the insulin receptor substrate 2 (Irs2) via mechanisms that include activation of CREB [546]

The anti-inflammatory pathways modulated by GLP-1 receptor activation (NF-kB suppression, macrophage polarization, Treg enhancement) are largely distinct from the pathways targeted by: Methotrexate: Folate metabolism disruption, different anti-inflammatory pathway TNF inhibitors (adalimumab, etanercept): Direct TNF blockade, whereas GLP-1 reduces TNF production upstream IL-6 inhibitors (tocilizumab): Receptor-level blockade, while GLP-1 reduces IL-6 production JAK inhibitors (tofacitinib, baricitinib): Different signaling pathway entirely Corticosteroids: Broad immunosuppression, while GLP-1 is immunomodulatory This pathway complementarity is why additive benefit is biologically plausible

10.3389/fcell.2024.1358755 Front Cell Dev Biol

In rodent models, GLP-1 receptor agonists have been shown to decrease both the consumption and the rewarding effects of opioids like heroin